.png)
TechAtlas has created over 120 landscape maps spanning the investable healthcare universe. We have mapped specific diseases (such as breast cancer) and capabilities that span a wide range of diseases (such as gene therapy or immuno-oncology), as well as the pipelines of pharmaceutical companies.
Acne/Rosacea
Acute Myeloid Luekemia
Immuno-oncology:
Adoptive Cell Therapy Targets (HEME)
Aesthetics
Aging + Age Related Diseases
Allergy
Alzheimer's Disease
Anti-Angiogenesis
Antibiotics: ABSSSI
Antibiotics: Pneumonia
Antifungals: Fungal Infections
Asthma
Atopic Dermatitis
B-Cell Malignancies
Benign Prostatic Hyperplasia (BPH)
Bladder Cancer
Cancer Metabolism
Immuno-oncology:
Cancer Vaccines
Immuno-oncology:
Cart-T
Cell Replication
Chronic Kidney Disease
Chronic Obstructive Pulmonary Disease
Colorectal Cancer
Orphan:
Complement
Complement System
Coronary Artery Disease
Cystic Fibrosis
Breast Cancer:
Driver
Drug Conjugated Technologies
Dyslipidemia
Orphan:
Endocrine
Epigenetics
Epilepsy
Fertility
Ophthalmology:
Front of the Eye
Functional Mitral Regurgitation
Orphan:
Gain of Function
Gene Therapy
Gene Therapy AAV
Immuno-oncology:
General
Orphan:
Genetic Inborn Errors of Metabolism
GI: Constipation & Diarrhea
Glioblastoma
Growth Signaling
Liver:
HBV/HDV
Liver:
HCV
Hearables
Heart Failure
Orphan:
Hematopoietic
Hepatocellular Carcinoma
Herpesviraidae
Human Immuno-deficiency Virus (HIV)
Orphan:
Immune
Immune GI Disorders
DIAGNOSTICS:
Infectious Disease
Ophthalmology:
Inflammation
Influenza
Orphan:
Lof Extracellular Factors
Lupus
Orphan:
Lysosomal
Melanoma
Menopause and Perimenopause
Metastasis
Melanoma:
MICAT
Microbiome
Migraine
Orphan:
Mitochondiral
Psychiatry:
Mood Disorders
Multiple Myeloma
Multiple Sclerosis
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Psychiatry:
Neurobehavioral Disorders
Orphan:
Neurodevelopmental
Orphan:
Neuromuscular (Muscle)
Orphan:
Neuromuscular (Neuro)
Neuropathic Pain
Breast Cancer:
Non-Driver
Non-Small Cell Lung Cancer
Liver
Non-Viral
Obesity
Diagnostics
Oncology
Orphan:
Ophthalmology
Opioids
Osteoarthritis
Ovarian Cancer
Overactive Bladder (OAB)
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Parkinson's Disease
Prophylactic Vaccines
Prostate Cancer
Psoriasis
Pulmonary Arterial Hypertension (PAH)
Renal Cell Carcinoma
DIAGNOSTICS:
Reproductive Genetic Testing
Women's Health:
Reproductive System Disorders
Ophthalmology:
Retina
Rheumatoid Arthritis
SC Delivery Technologies
Psychiatry:
Schizophrenia
Sensorineural Hearing Loss and Related Symptoms
Small Cell Lung Cancer (SCLC)
IMMUNO-ONCOLOGY:
SOLID TUMOR CELL THERAPIES
Stroke
Thrombosis
Type 1 Diabetes
Type 2 Diabetes
Abbvie: Non-Oncology + immunology
Abbvie: Oncology + immunology
Alexion
Biogen: Core Growth Areas
Biogen: Emerging Growth Areas
Biomarin
Bristol-Myers Squibb
Gilead
GSK: Strategy map
GSK: Vaccines + Other
Novartis
Novartis: Oncology
Novo Nordisk
Pfizer: Oncology + Rare Disease
Pfizer: Strategy Map
Roche
Roche: Oncology
Sanofi: Oncology + Immunology
Sanofi: Strategy Map
Shire
Teva
Alternative Food Protein
Corn Biotech Traits
Negative Emissions Technology
Abbvie: Non-Oncology + immunology
Abbvie: Oncology + immunology
Acne/Rosacea
Acute Myeloid Luekemia
Immuno-oncology:
Adoptive Cell Therapy Targets (HEME)
Aesthetics
Aging + Age Related Diseases
Alexion
Allergy
Alternative Food Protein
Alzheimer's Disease
Anti-Angiogenesis
Antibiotics: ABSSSI
Antibiotics: Pneumonia
Antifungals: Fungal Infections
Asthma
Atopic Dermatitis
B-Cell Malignancies
Benign Prostatic Hyperplasia (BPH)
Biogen: Core Growth Areas
Biogen: Emerging Growth Areas
Biomarin
Bladder Cancer
Bristol-Myers Squibb
Cancer Metabolism
Immuno-oncology:
Cancer Vaccines
Immuno-oncology:
Cart-T
Cell Replication
Chronic Kidney Disease
Chronic Obstructive Pulmonary Disease
Colorectal Cancer
Orphan:
Complement
Complement System
Corn Biotech Traits
Coronary Artery Disease
Cystic Fibrosis
Breast Cancer:
Driver
Drug Conjugated Technologies
Dyslipidemia
Orphan:
Endocrine
Epigenetics
Epilepsy
Fertility
Ophthalmology:
Front of the Eye
Functional Mitral Regurgitation
Orphan:
Gain of Function
Gene Therapy
Gene Therapy AAV
Immuno-oncology:
General
Orphan:
Genetic Inborn Errors of Metabolism
GI: Constipation & Diarrhea
Gilead
Glioblastoma
Growth Signaling
GSK: Strategy map
GSK: Vaccines + Other
Liver:
HBV/HDV
Liver:
HCV
Hearables
Heart Failure
Orphan:
Hematopoietic
Hepatocellular Carcinoma
Herpesviraidae
Human Immuno-deficiency Virus (HIV)
Orphan:
Immune
Immune GI Disorders
DIAGNOSTICS:
Infectious Disease
Ophthalmology:
Inflammation
Influenza
Orphan:
Lof Extracellular Factors
Lupus
Orphan:
Lysosomal
Melanoma
Menopause and Perimenopause
Metastasis
Melanoma:
MICAT
Microbiome
Migraine
Orphan:
Mitochondiral
Psychiatry:
Mood Disorders
Multiple Myeloma
Multiple Sclerosis
Myelodysplastic Syndromes (MDS)
Myeloproliferative Neoplasms (MPN)
Negative Emissions Technology
Psychiatry:
Neurobehavioral Disorders
Orphan:
Neurodevelopmental
Orphan:
Neuromuscular (Muscle)
Orphan:
Neuromuscular (Neuro)
Neuropathic Pain
Breast Cancer:
Non-Driver
Non-Small Cell Lung Cancer
Liver
Non-Viral
Novartis
Novartis: Oncology
Novo Nordisk
Obesity
Diagnostics
Oncology
Orphan:
Ophthalmology
Opioids
Osteoarthritis
Ovarian Cancer
Overactive Bladder (OAB)
Pancreatic Cancer
Pancreatic Neuroendocrine Tumors
Parkinson's Disease
Pfizer: Oncology + Rare Disease
Pfizer: Strategy Map
Prophylactic Vaccines
Prostate Cancer
Psoriasis
Pulmonary Arterial Hypertension (PAH)
Renal Cell Carcinoma
DIAGNOSTICS:
Reproductive Genetic Testing
Women's Health:
Reproductive System Disorders
Ophthalmology:
Retina
Rheumatoid Arthritis
Roche
Roche: Oncology
Sanofi: Oncology + Immunology
Sanofi: Strategy Map
SC Delivery Technologies
Psychiatry:
Schizophrenia
Sensorineural Hearing Loss and Related Symptoms
Shire
Small Cell Lung Cancer (SCLC)
IMMUNO-ONCOLOGY:
SOLID TUMOR CELL THERAPIES
Stroke
Teva
Thrombosis
Type 1 Diabetes
Type 2 Diabetes
“We are privileged to be taught everyday by the greatest scientific minds in the industry and academia. Our curiosity and work drive us to restore context to data and knowledge, from which emerge remarkable insights, each one potentially inspiring investment in outstanding people and technologies. But to have the greatest positive social impact, we must share those insights in an effort to enrich discourse and spark collaboration among all stakeholders, including patients, physicians, innovators, researchers, policy makers, and the next generation searching for inspiration.”
Our website uses cookies to distinguish you from other users of our website. This helps us to provide you with a good experience when you browse our website, and also allows us to improve our site. By continuing, you accept the use of these cookies.
dismiss
